Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
liraglutide (victoza) (1 trial)
sitagliptin (januvia) (3 trials)
vildagliptin (1 trial)
Diabetes Mellitus, Type 2 (Phase 3)
Trials (3 total)
Trial APIs (3 total)